P
Paul M. Arguin
Researcher at Centers for Disease Control and Prevention
Publications - 95
Citations - 2815
Paul M. Arguin is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Malaria & Public health surveillance. The author has an hindex of 30, co-authored 95 publications receiving 2594 citations. Previous affiliations of Paul M. Arguin include International Organization for Migration.
Papers
More filters
Journal ArticleDOI
Malaria Surveillance - United States, 2015.
TL;DR: The number of malaria cases diagnosed in the United States has been increasing since the mid-1970s and the number of cases decreased by 208 from 2014 to 2015, but the only region with significantly fewer imported cases in 2015 was West Africa.
Journal ArticleDOI
Doxycycline for Malaria Chemoprophylaxis and Treatment: Report from the CDC Expert Meeting on Malaria Chemoprophylaxis
TL;DR: Doxycycline is especially useful as a prophylaxis in areas with chloroquine and multidrug-resistant Plasmodium falciparum malaria.
Malaria surveillance--United States, 2009.
TL;DR: Treatment of malaria, while appropriate for the majority of cases, was insufficient for a large number of P. vivax and P. ovale infections, putting patients at risk for relapsing malaria.
Meeting Report Doxycycline for Malaria Chemoprophylaxis and Treatment: Report from the CDC Expert Meeting on Malaria Chemoprophylaxis
TL;DR: The only U.S. Food and Drug Administration (FDA)-approved indication for the use of doxycycline for malaria is for prophylaxis of Plasmodium falciparum in shortterm travelers (< 4 months) to areas with chloroquine and/or pyrimethamine-sulfadoxine-resistant strains as discussed by the authors.
Journal ArticleDOI
Risk Factors for Nipah Virus Infection among Abattoir Workers in Singapore
Madeleine H.L. Chew,Paul M. Arguin,David K. Shay,Kee Tai Goh,Pierre E. Rollin,Wun Ju Shieh,Sherif R. Zaki,Paul A. Rota,Ai Ee Ling,Thomas G. Ksiazek,Suok Kai Chew,Larry J. Anderson +11 more
TL;DR: Contact with live pigs appeared to be the most important risk factor for human Nipah virus infection and direct contact with live, potentially infected pigs should be minimized to prevent transmission of this potentially fatal zoonosis to humans.